PPARG and polycystic ovary syndrome: Furthermore, Antoine et al. explored the relationship of the PPARγ Pro12Ala and silent exon 6 (His447His) polymorphisms with the clinical features of PCOS and stated that Pro12Ala and His447His did not seem to increase the risk of PCOS or its component phenotypes in PCOS patients [59].